In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2

Leucine-rich repeat kinase 2 (LRRK2) is a complex, multidomain protein which is considered a valuable target for potential disease-modifying therapeutic strategies for Parkinson's disease (PD). In mammalian cells and brain, LRRK2 is phosphorylated and treatment of cells with inhibitors of LRRK2...

Descripción completa

Detalles Bibliográficos
Autores principales: Vancraenenbroeck, Renée, De Raeymaecker, Joren, Lobbestael, Evy, Gao, Fangye, De Maeyer, Marc, Voet, Arnout, Baekelandt, Veerle, Taymans, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042160/
https://www.ncbi.nlm.nih.gov/pubmed/24917786
http://dx.doi.org/10.3389/fnmol.2014.00051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042160/
https://www.ncbi.nlm.nih.gov/pubmed/24917786
http://dx.doi.org/10.3389/fnmol.2014.00051

Ejemplares similares